Leflunomide for Maintenance of Remission in IgG4 Related Disease

Clinical trial NCT02703194 · COMPLETED

Trial details

NCT number: NCT02703194
Sponsor: Chinese PLA General Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Immunoglobulin G4 Related Sclerosing Disease

Start date: 2016-03-01
Primary completion: 2019-01-01
Enrollment: 68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.